Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP290939
下载链接
链接失效反馈官方服务：
资源简介：
To investigate the effect of cyproheptadine treatment on bladder cancer cells, expression profile was compared in BFTC905 cells treatment DMSO vs 55µM CPH. Overall design: BFTC 905 bladder cancer cells were treated with DMSO (control) or 55µM CPH (treatment).
创建时间：
2021-04-29
